Home/Filings/4/0000907254-25-000069
4//SEC Filing

Laycock Willoughby B. 4

Accession 0000907254-25-000069

CIK 0000907254other

Filed

May 12, 8:00 PM ET

Accepted

May 13, 5:28 PM ET

Size

24.4 KB

Accession

0000907254-25-000069

Insider Transaction Report

Form 4
Period: 2025-05-09
Laycock Willoughby B.
DirectorSVP-Res. Design/Mrkt Research
Transactions
  • Award

    Performance Shares

    2025-05-09+500500 total
    Exercise: $0.00From: 2030-05-09Exp: 2030-05-09Common Stock (500 underlying)
  • Award

    Common Stock

    2025-05-09+5004,101.068 total
Holdings
  • Director Stock Option

    Exercise: $33.79From: 2023-05-12Exp: 2033-05-12Common Stock (2,500 underlying)
    2,500
  • Performance Shares

    Exercise: $0.00From: 2029-05-17Exp: 2029-05-17Common Stock (400 underlying)
    400
  • Employee Stock Option

    Exercise: $55.71From: 2019-05-03Exp: 2029-05-03Common Stock (5,000 underlying)
    5,000
  • Director Stock Option

    Exercise: $55.71From: 2019-05-03Exp: 2029-05-03Common Stock (2,500 underlying)
    2,500
  • Employee Stock Option

    Exercise: $50.00From: 2020-04-24Exp: 2030-04-24Common Stock (10,000 underlying)
    10,000
  • Director Stock Option

    Exercise: $43.89From: 2021-05-07Exp: 2031-05-07Common Stock (2,500 underlying)
    2,500
  • Employee Stock Option

    Exercise: $33.79From: 2023-05-12Exp: 2033-05-12Common Stock (10,000 underlying)
    10,000
  • Common Stock

    (indirect: By Spouse)
    249.952
  • Director Stock Option

    Exercise: $50.00From: 2020-04-24Exp: 2030-04-24Common Stock (2,500 underlying)
    2,500
  • Employee Stock Option

    Exercise: $43.89From: 2021-05-07Exp: 2031-05-07Common Stock (10,000 underlying)
    10,000
  • Employee Stock Option

    Exercise: $47.90From: 2022-05-13Exp: 2032-05-13Common Stock (10,000 underlying)
    10,000
  • Director Stock Option

    Exercise: $47.90From: 2022-05-13Exp: 2032-05-13Common Shares (2,500 underlying)
    2,500
  • Phantom Stock

    Common Stock (3,934.656 underlying)
    3,934.656
Footnotes (6)
  • [F1]Represents restricted shares of Common Stock. Such shares vest on the first five anniversaries of May 9, 2025 in equal annual installments, assuming continued employment.
  • [F2]The options vest 25% per year over four years from the date of grant.
  • [F3]New phantom shares are issuable pursuant to the Issuers Deferred Compensation Plan for Directors, as amended and restated effective May 17, 2024 (the Deferred Compensation Plan), under its 2024 Stock Incentive Plan. Phantom shares issued prior to May 17, 2024, continue to be subject to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan.
  • [F4]The conversion of phantom shares issued on or after May 17, 2024, into shares of the Issuers common stock is governed pursuant to terms of the Issuers Deferred Compensation Plan under its 2024 Stock Plan and the reporting persons Deferred Fee Agreement. The conversion of phantom shares issued prior to May 17, 2024, into shares of the Issuers common stock is governed pursuant to the terms of the Issuers deferred compensation plan for directors in effect prior to the amendment and restatement of the Deferred Compensation Plan and the reporting persons Deferred Fee Agreement.
  • [F5]Includes 72.670 shares awarded April 30, 2025 as dividend reinvestments on shares of phantom stock held by the reporting person pursuant to the Deferred Compensation Plan.
  • [F6]The performance share award provides for the grant of restricted shares of Common Stock on each of the five anniversaries of May 9, 2025 in equal annual installments. The number of restricted shares of such grant that vest, if any, is (i) subject to cliff-vesting on May 9, 2030, and (2) achievement of performance criteria relating to the Companys target Funds from Operations available to common stockholders and noncontrolling interests (FFO) measured against an FFO amount included in the budget established by the Board of Directors annually prior to the start of such calendar year.

Issuer

SAUL CENTERS, INC.

CIK 0000907254

Entity typeother

Related Parties

1
  • filerCIK 0001771496

Filing Metadata

Form type
4
Filed
May 12, 8:00 PM ET
Accepted
May 13, 5:28 PM ET
Size
24.4 KB